Form 4: Sight Sciences Chief Legal Officer Sells Shares to Cover Tax Obligations

Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, sold 1,810 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Summary

• Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., sold 1,810 shares of common stock on January 8, 2025.
• The sale was executed at a price of $3.259 per share.
• This transaction was made to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Hayden directly owns 152,013 shares of Sight Sciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax liabilities are a common practice across various industries.
• The sale of 1,810 shares is relatively small compared to the total holdings of 152,013 shares, suggesting it is a routine tax-related transaction rather than a significant divestment.
• Similar transactions are frequently observed in filings of other publicly traded companies, such as those in the medical device sector like Alcon (ALC) or Johnson & Johnson (JNJ), where executives often manage their stock holdings for tax purposes.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Sight Sciences, stock sale, insider trading, Jeremy B. Hayden, tax liability, restricted stock units, SGHT